Tricia Abe

IVIg alternative for surgery patients with bleeding disorder

Tuesday, February 09, 2021
With an anticipated global shortage of immune globulin products, finding alternatives to IVIg can help improve availability of a drug in high demand. A recent study shows that eltrombopag, an oral medication that stimulates the production of platelets, is an effective alternative to IVIg for patients with immune thrombocytopenia who need surgery.

Dr. Celina Montemayor-Garcia on the potential of genomics to shape the future of transfusion medicine

Thursday, January 14, 2021
Dr. Celina Montemayor-Garcia is a researcher and transfusion medicine specialist whose main interest is understanding how genomics and bioinformatics can be used to improve care for transfusion patients. She spoke to us about advances in precision medicine and genomics, and what they could mean for the future of blood systems.

Treat the bleed: Practical guidance for physicians developed by leaders in transfusion medicine

Thursday, November 05, 2020
Canada’s leading experts in transfusion medicine came together to collaborate on Treat the Bleed, a website that provides guidance for front-line physicians in treating bleeding patients.

Improving transfusion practice through serology education

Thursday, October 22, 2020
With funding from Canadian Blood Services’ BloodTechNet Award Program, transfusion medicine specialists developed, an online curriculum that supports serology education.

Blood transfusion during the pandemic: strategies in a time of uncertainty

Friday, August 07, 2020
COVID-19 has brought major implications for blood transfusion practices: uncertain demand patterns, reduced donations and loss of staff. A recent publication synthesizes studies that address the transfusion chain and provide guidance during times of potential or actual shortage. Dr. Mindy Goldman, medical director at Canadian Blood Services, is one of the study’s authors.

Hemophilia’s global impact is greater than previously thought

Friday, April 17, 2020
World Hemophilia Day, an international awareness day for hemophilia and other bleeding disorders, is held annually on April 17. Hemophilia, an inherited blood disorder that affects mostly men, impairs a person’s ability to clot blood. A study led by a researcher from the McMaster Centre for Transfusion Research suggests more men have hemophilia worldwide than previously thought, highlights the need for improved hemophilia care, and helps predict demand for the plasma protein products used to treat patients.

Fibrinogen replacement products: how do they stack up against each other?

Thursday, March 12, 2020
For patients who have cardiac surgery, the risk of severe blood loss is high if they have a condition called acquired hypofibrinogenemia — this means they have an undersupply of an essential blood clotting protein called fibrinogen. Doctors aim to minimize their bleeding with a fibrinogen replacement product, either cryoprecipitate or fibrinogen concentrate, to restore clotting factors to normal levels. A recent study that compared both products could have an impact on how cardiac patients are treated in Canada.

Protecting patient safety: how tracking adverse events can help

Thursday, January 23, 2020
Although it doesn’t happen often, sometimes patients will have a bad reaction during or after a blood transfusion. Surveillance systems set up to monitor the safety of the blood supply in Canada keep track of incidents like these so that issues potentially affecting patient safety can be identified. A recently published guide on reporting adverse transfusion events, available on Canadian Blood Services’ professional education website, helps make the reporting process easier to understand.

Does sex matter in red blood cell transfusions?

Monday, December 23, 2019
When doctors select compatible red blood cell units for transfusion into a patient, they don’t consider the sex of the patient and whether the donor is the same (sex-matched) or opposite sex (sex-mismatched). But a study led by Dr. Michelle Zeller, Canadian Blood Services medical officer and assistant professor in the department of medicine at McMaster University, suggests that the role of donor sex in red blood cell compatibility may be worth a closer look.

Patients with non-ABO red blood cell antibodies: transfusion best practices for professionals

Tuesday, December 10, 2019
When a patient has unexpected red blood cell antibodies (non-ABO) in their blood, selecting compatible red blood cell donor units for transfusion is critical. New serological best practices for health-care providers, available on Canadian Blood Service’s professional education website, help ensure patients receive red blood cell units that are the best match for them.